Novartis announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Bloomberg's Scarlet Fu on the impact of pharma tariffs.

Novartis announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Bloomberg's Scarlet Fu on the impact of pharma tariffs.

Listen for top interviews from Bloomberg News. 

Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Novartis CEO Vas Narasimhan Talks Psoriasis Drug, China Growth, M&A

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/30c9cbcb-02f8-438f-90e7-b31d014d51ef/transcript

Chris Studley, USTA Managing Director of Event Services talked with Bloomberg's Tim Stenovec and Molly Smith on special edition of Bloomberg Businessweek Daily live at the US Open. He discussed how the US Open is as much a food-and-drink event as a tennis tournament. He says attendance and sales are up this year, noting more than 300,000 people came through during Fan Week and projecting about 800,000 Honey Deuces sold, up from 738,000 last year.

Chris Studley, USTA Managing Director of Event Services talked with Bloomberg's Tim Stenovec and Molly Smith on special edition of Bloomberg Businessweek Daily live at the US Open. He discussed how the US Open is as much a food-and-drink event as a tennis tournament. He says attendance and sales are up this year, noting more than 300,000 people came through during Fan Week and projecting about 800,000 Honey Deuces sold, up from 738,000 last year.

USTA's Chris Studley Talks Food and Drink at the US Open

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a274f9a6-5d49-4044-9505-b4bb015e2e87/transcript

Jon Wertheim, Executive Editor of Sports Illustrated & 60 Minutes Correspondent talked with Bloomberg's Tim Stenovec and Molly Smith on special edition of Bloomberg Businessweek Daily live at the US Open. He talked about the US Open's partnership with Kalshi along with the influx of online influencers attending the tournament.

Jon Wertheim, Executive Editor of Sports Illustrated &amp; 60 Minutes Correspondent talked with Bloomberg's Tim Stenovec and Molly Smith on special edition of Bloomberg Businessweek Daily live at the US Open. He talked about the US Open's partnership with Kalshi along with the influx of online influencers attending the tournament.

Sports Illustrated Executive Editor Jon Wertheim Talks US Open Influencers

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a1bb144a-3ca3-4f41-8209-b4bb015e2e86/transcript

Brian Kelly, CEO at "The Points Guy" sat down with Bloomberg's Tom Keene and Scarlet Fu on Bloomberg Money to discuss how he built the site in 2010 while working at Morgan Stanley and using corporate travel spending to rack up credit card points. He says the site took off within 11 months after he began sharing tips for corporate travelers. Kelly also defends his broader thesis that points are a real currency and says loyalty programs remain highly profitable for airlines and banks.

Brian Kelly, CEO at "The Points Guy" sat down with Bloomberg's Tom Keene and Scarlet Fu on Bloomberg Money to discuss how he built the site in 2010 while working at Morgan Stanley and using corporate travel spending to rack up credit card points. He says the site took off within 11 months after he began sharing tips for corporate travelers. Kelly also defends his broader thesis that points are a real currency and says loyalty programs remain highly profitable for airlines and banks.

"The Points Guy" CEO Brian Kelly Talks Founding the Site

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/12bb32cf-dc3c-4382-aa82-b4bb015e2e85/transcript

Novartis CEO Vas Narasimhan Talks Psoriasis Drug, China Growth, M&A

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips